Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia
about
Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIIIAn autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor dom'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCCA Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar AtaxiaIFRD1 is a candidate gene for SMNA on chromosome 7q22-q23.Therapeutic prospects for spinocerebellar ataxia type 2 and 3.Effect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells.Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer.Loss of Purkinje cells in the PKCgamma H101Y transgenic mouseStructural basis of protein kinase C isoform functionEstablishment of a novel fluorescence-based method to evaluate chaperone-mediated autophagy in a single neuron.In vivo evidence for mTORC2-mediated actin cytoskeleton rearrangement in neuronsAutoantibody-mediated disorders of the central nervous system.Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future.1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase CProtein kinase C as a stress sensor.Protein kinase C gamma mutations in the C1B domain cause caspase-3-linked apoptosis in lens epithelial cells through gap junctions.Protection from ataxia-linked apoptosis by gap junction inhibitorsRecent advances in hereditary spinocerebellar ataxias.Human ataxias: a genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signaling.On autosomal dominant cerebellar ataxia (ADCA) other than polyglutamine diseases, with special reference to chromosome 16q22.1-linked ADCA.Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphologyAge-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice.A duplication at chromosome 11q12.2-11q12.3 is associated with spinocerebellar ataxia type 20Physiology and pathophysiology of canonical transient receptor potential channelsPKCgamma-induced trafficking of AMPA receptors in embryonic zebrafish depends on NSF and PICK1Genetic and molecular aspects of spinocerebellar ataxias.Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a modelLoss of protein kinase Cgamma in knockout mice and increased retinal sensitivity to hyperbaric oxygen.Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.Deregulation of the actin cytoskeleton and macropinocytosis in response to phorbol ester by the mutant protein kinase C gamma that causes spinocerebellar ataxia type 14.Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.Cerebellar ataxias: β-III spectrin's interactions suggest common pathogenic pathways.Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.IP3 receptor mutations and brain diseases in human and rodents.Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.Molecular pathophysiology of neurodegenerative disease caused by γPKC mutations.Understanding the physiopathology of paraneoplastic and genetic cerebellar ataxia.SCA14 mutation V138E leads to partly unfolded PKCγ associated with an exposed C-terminus, altered kinetics, phosphorylation and enhanced insolubilization.
P2860
Q21202869-3EA8D98C-2A05-4241-8F8E-790AE3DE84F4Q22000623-5880800B-23AE-4DCE-9FA3-A14F47B1DD0AQ24531256-4AF97F37-5EB4-4D0F-A246-582FE2FD64FDQ26786113-DB8662ED-1552-4D43-A081-21A6019253A6Q28115409-DED17A3A-51A5-4D6C-979F-E1D69D68912AQ30376687-72EB3A0A-58E8-40ED-922E-33BE0C025D8FQ30410969-08EAEF84-36BF-4A77-87E7-8B87A6F9C6C4Q30497111-DD725E44-EB30-4533-A3DB-D0BAFEAEDE92Q33248003-E494BEC1-A95E-4E26-AD8F-E353BEB5ED19Q33836298-892E2FBA-202D-4BA2-84AB-D9E74DFA04AAQ33973406-79CF90B1-154F-4C25-A3DB-1299C604BC49Q34170664-51A13F9C-4B42-41A6-A59E-B50C93933F18Q34362461-09CB491A-E3EA-419E-97B7-BF49A5A9DE16Q34733326-6118C492-A447-460B-9365-0B003C42E4E5Q35589292-9D7FA9AB-90FB-4576-A6B8-83082ADCADA8Q35844553-67FF75BD-FA99-4250-8FBB-A9AE6E0AC8F1Q36003170-888E5732-E4CD-4DB2-9920-E4A7A95761F9Q36073050-F2839444-3C32-485D-9930-A28096B05277Q36082552-8055D97D-6092-43ED-AD09-E2EDB38C2E91Q36085900-B55FB783-9F27-46D8-BF54-7D8720AB3EE3Q36384774-433D3946-2195-4DD3-B90D-853BFC9402B7Q36589172-274E10CD-600F-499A-BDB1-C182777CE7DEQ36772577-C2C603AC-35EE-42CE-9CE4-D5BFA1E6466BQ36890888-F852119D-1494-48F3-B302-240A3C9E81DDQ36987090-3A71051C-980F-40E5-BECB-DD60DFA76EFDQ37072447-B4C5E528-9596-4C38-8B6F-F64CFB3D042AQ37167817-939C01EB-119C-409D-A422-B874BA070752Q37196137-4AF4AF11-AEBD-4181-939B-E26144410A92Q37200324-E08279D5-654E-409E-B012-8F19B74C9F1DQ37243724-B2C853AA-97C9-469D-9E7B-35FC0AB1616BQ37619548-8A63FB58-1B1B-40C6-BEBB-99C5EA9FA7A3Q38642817-A2E535A9-CD79-4D63-8FEA-D02ECFD153E0Q38808532-2A889BB1-2602-4BFF-B5B3-40C650BC471AQ38915057-C172302F-FF44-439D-A600-217F28CEDF82Q39112358-8A9B3A4A-229D-46FC-90E2-562A53A4A419Q39140608-E8EEF5C1-BD73-454F-BE9F-8A348916E549Q41461988-3ADC1632-E55C-451C-8057-8E12C6797873Q42494093-47C51A79-EED0-452F-A875-212785AEF2CCQ42718371-100A0E41-B50F-4169-BBB1-552B04272480Q43905253-411CC5E4-77F8-4C8E-9D9D-FDD48B8A6CBB
P2860
Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Missense mutations in the regu ...... nonepisodic cerebellar ataxia
@ast
Missense mutations in the regu ...... nonepisodic cerebellar ataxia
@en
type
label
Missense mutations in the regu ...... nonepisodic cerebellar ataxia
@ast
Missense mutations in the regu ...... nonepisodic cerebellar ataxia
@en
prefLabel
Missense mutations in the regu ...... nonepisodic cerebellar ataxia
@ast
Missense mutations in the regu ...... nonepisodic cerebellar ataxia
@en
P2093
P2860
P356
P1476
Missense mutations in the regu ...... nonepisodic cerebellar ataxia
@en
P2093
Christophe L M J Verlinde
David Nochlin
Dong-Hui Chen
Hillary Lipe
John Wolff
Laura Bylenok
Magali Fernandez
Mark Matsushita
Thomas D Bird
Wendy H Raskind
P2860
P304
P356
10.1086/373883
P407
P50
P577
2003-03-17T00:00:00Z